CONCLUSION
Osteoporosis is one of the major health problems worldwide causing bone mass reductions resulting in increased fracture risk. The major treatment strategies include anabolic and anti resorptive drug classes. Recombinant human Parathyroid Hormone is an anabolic agent more effective in the treatment of osteoporotic fractures and increasing Bone Mineral Density (BMD) as compared to Bisphosphonates that are anti resorptive agents. However in Pakistan Bisphosphonate therapy is prescribed more often due to cost effectives and easy availability as compared to rhPTH therapy that is highly expensive and hardly available.